287 related articles for article (PubMed ID: 35970234)
21. Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.
Gallardo M; Munk MR; Kurmann T; De Zanet S; Mosinska A; Karagoz IK; Zinkernagel MS; Wolf S; Sznitman R
Ophthalmol Retina; 2021 Jul; 5(7):604-624. PubMed ID: 33971352
[TBL] [Abstract][Full Text] [Related]
22. The Impact of Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review.
Patil NS; Mihalache A; Dhoot AS; Popovic MM; Muni RH; Kertes PJ
Ophthalmic Surg Lasers Imaging Retina; 2023 Jan; 54(1):50-58. PubMed ID: 36626212
[TBL] [Abstract][Full Text] [Related]
23. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF.
Starr MR; Mahr MA; Iezzi R; Barkmeier AJ; Bakri SJ
Semin Ophthalmol; 2020 May; 35(4):205-209. PubMed ID: 32721186
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.
Sen P; Gurudas S; Ramu J; Patrao N; Chandra S; Rasheed R; Nicholson L; Peto T; Sivaprasad S; Hykin P
Ophthalmol Retina; 2021 Nov; 5(11):1115-1124. PubMed ID: 33610836
[TBL] [Abstract][Full Text] [Related]
25. Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
Holekamp N; Gentile B; Giocanti-Aurégan A; García-Layana A; Peto T; Viola F; Kertes PJ; Mirt M; Kotecha A; Lambert J; Lewis HB; Chi GC
Ophthalmic Res; 2024; 67(1):311-321. PubMed ID: 38679018
[TBL] [Abstract][Full Text] [Related]
26. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
27. Current Outcomes of Anti-VEGF Therapy in the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusions: A Meta-Analysis.
Spooner K; Hong T; Fraser-Bell S; Chang AA
Ophthalmologica; 2019; 242(3):163-177. PubMed ID: 31158837
[TBL] [Abstract][Full Text] [Related]
28. Treatment patterns for retinal diseases in patients newly-treated with anti-VEGF agents: A retrospective analysis of claims data from the Japan Medical Data Center database.
Kawasaki R; Bauer M; Bezlyak V; Ogura Y
Jpn J Ophthalmol; 2021 Mar; 65(2):215-226. PubMed ID: 33420855
[TBL] [Abstract][Full Text] [Related]
29. The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
Jakobsen NS; Larsen DA; Bek T
Acta Ophthalmol; 2018 Nov; 96(7):744-748. PubMed ID: 29687595
[TBL] [Abstract][Full Text] [Related]
30. Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.
Byeon SH; Kwon YA; Oh HS; Kim M; Kwon OW
J Ocul Pharmacol Ther; 2007 Aug; 23(4):387-94. PubMed ID: 17803438
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 Pandemic Lockdowns' Impact on Visual Acuity of Diabetic Macular Edema: A Large Cohort.
Gomel N; Shor R; Lippin N; Segal O; Greenbaum E; Schwartz S; Trivizki O; Loewenstein A; Rabina G
Ophthalmologica; 2023; 246(1):1-8. PubMed ID: 36380651
[TBL] [Abstract][Full Text] [Related]
32. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
33. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
Papadia M; Misteli M; Jeannin B; Herbort CP
Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
[TBL] [Abstract][Full Text] [Related]
34. Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis.
Patil NS; Hatamnejad A; Mihalache A; Popovic MM; Kertes PJ; Muni RH
Ophthalmologica; 2022; 245(6):500-515. PubMed ID: 36288721
[TBL] [Abstract][Full Text] [Related]
35. Consequences of anti-vascular endothelial growth factor treatment lapse in patients with retinal vein occlusion.
Liu JC; Alsaloum P; Iyer AI; Kaiser PM; Singh RP
Eye (Lond); 2023 Feb; 37(3):453-458. PubMed ID: 35132210
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis.
Sangroongruangsri S; Ratanapakorn T; Wu O; Anothaisintawee T; Chaikledkaew U
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):903-916. PubMed ID: 30071180
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal dexamethasone implant versus anti-VEGF injection for treatment-naïve patients with retinal vein occlusion and macular edema: a 12-month follow-up study.
Chiquet C; Dupuy C; Bron AM; Aptel F; Straub M; Isaico R; Romanet JP; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2095-102. PubMed ID: 25673251
[TBL] [Abstract][Full Text] [Related]
39. Long-term dynamic changes and influencing factors of corneal morphology after multiple intravitreal injections of anti-VEGF drugs.
Qi Y; Li C; Ye S; Zhang Z; Li S; Zhang L
Medicine (Baltimore); 2024 Apr; 103(17):e37937. PubMed ID: 38669379
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
